Clinical Trials Logo

Clinical Trial Summary

Gestational diabetes is the most common complication during pregrancy. With a screening between week 24 and 28 of gestation women with gestational diabetes can be identified and treated. Treatment comprises modification of diet and in some cases taking medication. This treatment lowers undesirable events like macrosomia or premature birth. However, unitl gestational diabetes is diagnosed the fetus is exposed to increased intrauterine glucose levels. The long-term effects of a well-managed gestational diabetes on the development of the offspring is still not well understood. Therefore, the PREG - Offspring study investigates several aspects of development in children from healthy and gestational diabetes mothers until adulthood.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Offspring Exposed to GDM and Control

NCT number NCT04722900
Study type Observational
Source University Hospital Tuebingen
Contact Louise Fritsche, Dr. rer. nat.
Phone 07071-2980687
Email louise.fritsche@med.uni-tuebingen.de
Status Recruiting
Phase
Start date January 15, 2021
Completion date September 15, 2036